Summary by Moomoo AI
Marpai, Inc., a leading health technology company, has announced a series of significant corporate events, including the upcoming Annual Meeting of Stockholders scheduled for May 6, 2024. The meeting will address several key proposals, such as the election of eight directors to the Board, the adoption of the Marpai, Inc. Global Stock Incentive Plan (2024), the ratification of UHY LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, and a proposal to amend the company's Certificate of Incorporation to authorize 2,000,000 shares of preferred stock. Additionally, stockholders will vote on the approval of the issuance of shares of Class A common stock pursuant to a proposed equity line of credit. These events are part of Marpai's strategic initiatives to strengthen its corporate governance, incentivize key personnel, and secure financial flexibility for future growth.